7.48% -0.046

Relmada Therapeutics Inc (RLMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Relmada Therapeutics Inc Azioni (RLMD) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	100.00% -	1.2592	1.3214	1.3634	1.2076
Operating Expenses	14.32% 22.99	26.83	22.69	26.03	28.15
Operating Income/Loss	14.32% -22.99	-26.83	-22.69	-26.03	-28.15
Nonoperating Income/Loss	30.31% 1.1597	1.6642	0.6906	0.7238	1.832
Income/Loss From Continuing Operations Before Tax	1,833% -21.83	1.2592	1.3214	-25.30	-26.32
Income/Loss From Continuing Operations After Tax	13.26% -21.83	-25.17	-22.00	-25.30	-26.32
Net Income/Loss	13.26% -21.83	-25.17	-22.00	-25.30	-26.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	30.13	-	30.10	30.10	30.10
Diluted Average Shares	30.13	-	30.10	30.10	30.10
Basic Earnings Per Share	13.25% -0.72	-0.83	-0.73	-0.84	-0.87
Diluted Earnings Per Share	194.74% -0.72	0.76	-1.31	-0.84	-0.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$77.72

0.40%

RPRX

$37.91

0.08%

INSM

$111.61

0.33%

SMMT

$29.13

0.65%

BNTX

$111.07

0.95%

ONC

$307.23

0.96%